Who owns CGON?
Institutional ownership of CG Oncology Inc. from Form 13F, Q2 2026
227 institutional managers reported holding CG Oncology Inc. (CGON) in Form 13F filings for Q2 2026, with 93,816,050 shares worth $6.7B. The largest reported holder was RTW Investments, LP. Managers that filed both quarters added a net 5,476,732 shares (+6.2%). 31 opened new positions and 37 sold out.
- Funds holding
- 227
- Value held
- $6.7B
- New / sold out
- 31 / 37
- Net shares, same filers
- +6.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CGON
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| RTW Investments, LP | $605M | 9.1% | 8,514,590 | Added |
| T. Rowe Price Investment Management, Inc. | $470M | 7.1% | 6,616,899 | Trimmed |
| Decheng Capital LLC | $453M | 6.8% | 6,371,669 | Unchanged |
| BlackRock, Inc. | $445M | 6.7% | 6,256,288 | Added |
| Wellington Management Group LLP | $378M | 5.7% | 5,324,751 | Trimmed |
| FMR LLC | $296M | 4.4% | 4,161,493 | Added |
| Price T Rowe Associates Inc | $270M | 4.1% | 3,805,010 | Added |
| TCG Crossover Management, LLC | $261M | 3.9% | 3,670,206 | Unchanged |
| Vanguard Portfolio Management LLC | $246M | 3.7% | 3,465,197 | Added |
| State Street Corp | $244M | 3.7% | 3,437,590 | Added |
| Vanguard Capital Management LLC | $236M | 3.5% | 3,316,793 | Added |
| Foresite Capital Management VI LLC | $168M | 2.5% | 2,369,574 | Added |
| Geode Capital Management, LLC | $153M | 2.3% | 2,153,277 | Added |
| Seven Fleet Capital Management LP | $134M | 2.0% | 1,886,236 | Added |
| EcoR1 Capital, LLC | $106M | 1.6% | 1,494,300 | Added |
| DV Trading LLC | $102M | 1.5% | 1,439,393 | Unchanged |
| Avidity Partners Management LP | $99.4M | 1.5% | 1,398,948 | Added |
| Franklin Resources Inc | $93.3M | 1.4% | 1,312,880 | Trimmed |
| Alliancebernstein L.p. | $93.0M | 1.5% | 1,374,149 | Added |
| Morgan Stanley | $83.6M | 1.3% | 1,177,109 | Added |
| Acorn Capital Advisors, LLC | $80.4M | 1.2% | 1,131,500 | Unchanged |
| Foresite Capital Management V, LLC | $76.7M | 1.2% | 1,079,050 | Added |
| Logos Global Management LP | $71.0M | 1.1% | 1,000,000 | Added |
| Bank of America Corp | $70.0M | 1.0% | 984,918 | Trimmed |
| UBS Group AG | $69.5M | 1.0% | 977,695 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 93,816,050 CGON shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Seven Fleet Capital Management LP Added+$129M
- RTW Investments, LP Added+$109M
- BlackRock, Inc. Added+$84.7M
- SG Americas Securities, LLC Added+$59.9M
- State Street Corp Added+$56.2M
- Jefferies Financial Group Inc. New+$54.7M
- American Century Companies Inc Added+$51.2M
- Morgan Stanley Added+$46.7M
- Geode Capital Management, LLC Added+$39.5M
- Bellevue Group AG New+$35.1M
Biggest sellers in Q2 2026
- Driehaus Capital Management LLC Sold out-$67.7M
- Braidwell LP Sold out-$66.7M
- Polar Capital Holdings Plc Trimmed-$47.0M
- Farallon Capital Management, L.l.c. Sold out-$45.6M
- Bank of America Corp Trimmed-$33.0M
- Point72 Asset Management, L.P. Sold out-$27.0M
- UBS Group AG Trimmed-$23.8M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trimmed-$21.5M
- Goldman Sachs Group Inc Trimmed-$21.4M
- Elmind Capital, LP Sold out-$19.7M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $990M and sold $589M; 92 added and 71 trimmed.
Schedule 13D and 13G filings on CGON
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15T. Rowe Price Investment Management, Inc. SCHEDULE 13G filed by CG Oncology Inc.Schedule 13G
- 2026-05-15RTW INVESTMENTS, LP SCHEDULE 13G filed by CG Oncology Inc.Schedule 13G
- 2025-11-12WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by CG Oncology Inc.Schedule 13G
- 2025-09-19Longitude Capital Partners IV, LLC SCHEDULE 13D filed by CG Oncology Inc.Schedule 13D
- 2025-08-06FMR LLC SCHEDULE 13G filed by CG Oncology Inc.Schedule 13G
Questions about CGON ownership
- Who owns CGON stock?
- 227 institutional investment managers reported CGON positions in their Form 13F filings for Q2 2026, holding 93,816,050 shares worth $6.7B in total. RTW Investments, LP reported the largest position.
- Are funds buying or selling CGON?
- In Q2 2026, 31 managers opened new CGON positions, 92 added, 71 trimmed and 37 sold out. Managers that filed in both quarters added a net 5,476,732 shares.
- How current is this CGON institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CGON by CUSIP. Options are left out. CGON news and filings · CGON insider trades · Top funds